Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01872754Phase 4Completed
Phase 4, randomised, single-blind trial of remifentanil (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Duration of patient's cough at Day 0. Started Jul 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01872754.